Literature DB >> 29082353

Application of induced pluripotent stem cells to model smooth muscle cell function in vascular diseases.

HaYeun Ji1, Hye Sung Kim1, Hae-Won Kim2,3, Kam W Leong1,4.   

Abstract

Vascular smooth muscle cells (SMC) play an essential role in remodeling the vasculature during disease progression. Induced pluripotent stem cells (iPSC) provide an attractive approach to obtain autologous SMC source for patient-specific disease modeling. Here we discuss the current methods to 1) derive functional SMC from iPSC, 2) model vascular diseases using SMC generated from patient-derived iPSC, and 3) modulate microenvironmental cues to enhance cellular differentiation and functionality and better mimic the physiological environment. We emphasize that continuous exploration of biomaterial technologies to engineer a more SMC-specific microenvironment will provide further insight on complex vascular diseases.

Entities:  

Year:  2017        PMID： 29082353      PMCID： PMC5654589          DOI： 10.1016/j.cobme.2017.02.005

Source DB:  PubMed          Journal:  Curr Opin Biomed Eng        ISSN： 2468-4511


  49 in total

1.  Defined three-dimensional microenvironments boost induction of pluripotency.

Authors:  Massimiliano Caiazzo; Yuya Okawa; Adrian Ranga; Alessandra Piersigilli; Yoji Tabata; Matthias P Lutolf
Journal:  Nat Mater       Date:  2016-01-11       Impact factor: 43.841

2.  Blood vessels engineered from human cells.

Authors:  Melissa Poh; Matthew Boyer; Amy Solan; Shannon L M Dahl; Dawn Pedrotty; Soma S R Banik; J Andrew McKee; Rebecca Y Klinger; Christopher M Counter; Laura E Niklason
Journal:  Lancet       Date:  2005 Jun 18-24       Impact factor: 79.321

3.  Marfan Sartan: a randomized, double-blind, placebo-controlled trial.

Authors:  Olivier Milleron; Florence Arnoult; Jacques Ropers; Philippe Aegerter; Delphine Detaint; Gabriel Delorme; David Attias; Florence Tubach; Sophie Dupuis-Girod; Henry Plauchu; Martine Barthelet; Francois Sassolas; Nicolas Pangaud; Sophie Naudion; Julie Thomas-Chabaneix; Yves Dulac; Thomas Edouard; Jean-Eric Wolf; Laurence Faivre; Sylvie Odent; Adeline Basquin; Gilbert Habib; Patrick Collignon; Catherine Boileau; Guillaume Jondeau
Journal:  Eur Heart J       Date:  2015-05-02       Impact factor: 29.983

4.  Atenolol versus losartan in children and young adults with Marfan's syndrome.

Authors:  Ronald V Lacro; Harry C Dietz; Lynn A Sleeper; Anji T Yetman; Timothy J Bradley; Steven D Colan; Gail D Pearson; E Seda Selamet Tierney; Jami C Levine; Andrew M Atz; D Woodrow Benson; Alan C Braverman; Shan Chen; Julie De Backer; Bruce D Gelb; Paul D Grossfeld; Gloria L Klein; Wyman W Lai; Aimee Liou; Bart L Loeys; Larry W Markham; Aaron K Olson; Stephen M Paridon; Victoria L Pemberton; Mary Ella Pierpont; Reed E Pyeritz; Elizabeth Radojewski; Mary J Roman; Angela M Sharkey; Mario P Stylianou; Stephanie Burns Wechsler; Luciana T Young; Lynn Mahony
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

5.  Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells.

Authors:  Tae-Hee Lee; Sun-Hwa Song; Koung Li Kim; Ji-Yeun Yi; Ga-Hee Shin; Ji Yeon Kim; Jihoon Kim; Yong-Mahn Han; Sang Hun Lee; Suk-Ho Lee; Sung Han Shim; Wonhee Suh
Journal:  Circ Res       Date:  2009-12-03       Impact factor: 17.367

Review 6.  Technical challenges in using human induced pluripotent stem cells to model disease.

Authors:  Krishanu Saha; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

Review 7.  Small-diameter vascular tissue engineering.

Authors:  Dawit G Seifu; Agung Purnama; Kibret Mequanint; Diego Mantovani
Journal:  Nat Rev Cardiol       Date:  2013-05-21       Impact factor: 32.419

8.  Biological and engineering design considerations for vascular tissue engineered blood vessels (TEBVs).

Authors:  Cristina E Fernandez; Hardean E Achneck; William M Reichert; George A Truskey
Journal:  Curr Opin Chem Eng       Date:  2014-02-01       Impact factor: 5.163

9.  Implantable tissue-engineered blood vessels from human induced pluripotent stem cells.

Authors:  Liqiong Gui; Biraja C Dash; Jiesi Luo; Lingfeng Qin; Liping Zhao; Kota Yamamoto; Takuya Hashimoto; Hongwei Wu; Alan Dardik; George Tellides; Laura E Niklason; Yibing Qyang
Journal:  Biomaterials       Date:  2016-06-14       Impact factor: 12.479

Review 10.  Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application.

Authors:  Sanjay Sinha; Dharini Iyer; Alessandra Granata
Journal:  Cell Mol Life Sci       Date:  2014-01-18       Impact factor: 9.261
View more
  4 in total

Review 1.  Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.

Authors:  Martha E Floy; Taylor D Mateyka; Koji L Foreman; Sean P Palecek
Journal:  Stem Cell Res       Date:  2020-04-27       Impact factor: 2.020

2.  Mechanical properties of stem cells from different sources during vascular smooth muscle cell differentiation.

Authors:  Ruikai Chen; Delphine Dean
Journal:  Mol Cell Biomech       Date:  2017

3.  peri-Adventitial delivery of smooth muscle cells in porous collagen scaffolds for treatment of experimental abdominal aortic aneurysm.

Authors:  Joscha Mulorz; Mahdis Shayan; Caroline Hu; Cynthia Alcazar; Alex H P Chan; Mason Briggs; Yan Wen; Ankita P Walvekar; Anand K Ramasubramanian; Joshua M Spin; Bertha Chen; Philip S Tsao; Ngan F Huang
Journal:  Biomater Sci       Date:  2021-10-12       Impact factor: 7.590

4.  Engineered Microenvironment for Manufacturing Human Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.

Authors:  Haishuang Lin; Xuefeng Qiu; Qian Du; Qiang Li; Ou Wang; Leonard Akert; Zhanqi Wang; Dirk Anderson; Kan Liu; Linxia Gu; Chi Zhang; Yuguo Lei
Journal:  Stem Cell Reports       Date:  2018-12-06       Impact factor: 7.765
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.